Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 104 (6) , 659-665
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyondContraception, 2020
- TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesContraception, 2019
- Simplified medical abortion screening: a demonstration projectContraception, 2018
- Efficacy of medical abortion prior to 6 gestational weeks: a systematic reviewContraception, 2018
- Barriers to Abortion Care and Their Consequences For Patients Traveling for Services: Qualitative Findings from Two StatesPerspectives on Sexual and Reproductive Health, 2017
- Outpatient medical abortion is safe and effective through 70days gestationContraception, 2015
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Mifepristone With Buccal Misoprostol for Medical AbortionObstetrics & Gynecology, 2015
- At What Cost? Payment for Abortion Care by U.S. WomenWomen's Health Issues, 2013
- First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic reviewContraception, 2013